NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,166 filers reported holding NOVARTIS A G in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $219,479 | -78.9% | 2,175 | -80.8% | 0.13% | -80.9% |
Q1 2023 | $1,041,808 | +19.0% | 11,324 | +17.3% | 0.68% | +32.4% |
Q4 2022 | $875,539 | -1.0% | 9,651 | -17.0% | 0.51% | -16.2% |
Q3 2022 | $884,000 | -9.4% | 11,624 | +0.7% | 0.61% | -4.1% |
Q2 2022 | $976,000 | -35.9% | 11,548 | -33.4% | 0.64% | -4.2% |
Q1 2022 | $1,522,000 | +79.3% | 17,346 | +78.8% | 0.67% | +72.1% |
Q4 2021 | $849,000 | -15.3% | 9,701 | -20.8% | 0.39% | -23.8% |
Q3 2021 | $1,002,000 | -8.8% | 12,247 | +1.7% | 0.51% | -8.8% |
Q2 2021 | $1,099,000 | +24.2% | 12,047 | +16.3% | 0.56% | +8.8% |
Q1 2021 | $885,000 | -9.0% | 10,357 | +0.5% | 0.51% | -12.2% |
Q4 2020 | $973,000 | +7.4% | 10,305 | -1.1% | 0.58% | -11.1% |
Q3 2020 | $906,000 | +56.5% | 10,415 | +57.0% | 0.66% | +46.8% |
Q2 2020 | $579,000 | -15.8% | 6,633 | -20.5% | 0.45% | -28.7% |
Q1 2020 | $688,000 | -24.8% | 8,346 | -13.6% | 0.63% | -7.7% |
Q4 2019 | $915,000 | +31.3% | 9,665 | +20.5% | 0.68% | +14.3% |
Q3 2019 | $697,000 | +135.5% | 8,020 | +147.5% | 0.59% | +99.3% |
Q2 2019 | $296,000 | +6.9% | 3,241 | +12.5% | 0.30% | +3.5% |
Q1 2019 | $277,000 | +35.1% | 2,881 | +20.6% | 0.29% | +16.6% |
Q4 2018 | $205,000 | – | 2,388 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |